-
Study aim
-
The present study aims to assess the safety and feasibility of selective dorsal rhizotomy in patients with spinal cord injury-induced spasticity.
-
Design
-
This study is a single arm, nonblinded, nonrandomized, phase 1 clinical trial on 15 patients to assess the safety and feasibility of study intervention.
-
Settings and conduct
-
A total of 15 patients will undergo selective dorsal rhizotomy in the present single-arm clinical trial. Since the aim of this study is to assess the safety and feasibility of the intervention, randomization and blinding will not be performed. Patients will be evaluated regarding the study outcomes at baseline, 1-week, 3-, and 6-month postoperatively.
-
Participants/Inclusion and exclusion criteria
-
Patients with cervical or thoracolumbar complete spinal cord injury (SCI)-induced intractable spasticity refractory to treatment for at least six months, modified Ashworth scale of at least three, and spasm frequency score of at least two will be included. Patients who have spasticity with etiologies other than SCI, concurrent traumatic brain injury, or a history of prior therapy with intrathecal baclofen will be exculded.
-
Intervention groups
-
A total of 15 patients with complete spinal cord injury-induced spasticity, will undergo selective dorsal rhizotomy. The procedure includes laminectomy or laminoplasty followed by partial division of dorsal nerve roots using intraoperative neurophysiologic monitoring.
-
Main outcome variables
-
The primary outcome measure of the study was the safety profile of the study intervention. Secondary outcome measures included modified Ashworth scale, spasm frequency scale, spinal cord injury spasticity evaluation tool, visual analog scale for spasticity, spinal cord independence measure, and Short Form 36 Health Survey Questionnaire.